|
|
|
|
| LEADER |
01000naa a22002652 4500 |
| 001 |
NLM153467290 |
| 003 |
DE-627 |
| 005 |
20231223064057.0 |
| 007 |
tu |
| 008 |
231223s2004 xx ||||| 00| ||eng c |
| 028 |
5 |
2 |
|a pubmed24n0512.xml
|
| 035 |
|
|
|a (DE-627)NLM153467290
|
| 035 |
|
|
|a (NLM)15688463
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a eng
|
| 100 |
1 |
|
|a Fennell, Diane
|e verfasserin
|4 aut
|
| 245 |
1 |
0 |
|a New tools 2004
|
| 264 |
|
1 |
|c 2004
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ohne Hilfsmittel zu benutzen
|b n
|2 rdamedia
|
| 338 |
|
|
|a Band
|b nc
|2 rdacarrier
|
| 500 |
|
|
|a Date Completed 03.02.2005
|
| 500 |
|
|
|a Date Revised 19.11.2015
|
| 500 |
|
|
|a published: Print
|
| 500 |
|
|
|a Citation Status MEDLINE
|
| 650 |
|
4 |
|a Journal Article
|
| 650 |
|
7 |
|a Carbolines
|2 NLM
|
| 650 |
|
7 |
|a Hypoglycemic Agents
|2 NLM
|
| 650 |
|
7 |
|a Insulin
|2 NLM
|
| 650 |
|
7 |
|a Thiophenes
|2 NLM
|
| 650 |
|
7 |
|a Tadalafil
|2 NLM
|
| 650 |
|
7 |
|a 742SXX0ICT
|2 NLM
|
| 650 |
|
7 |
|a insulin glulisine
|2 NLM
|
| 650 |
|
7 |
|a 7XIY785AZD
|2 NLM
|
| 650 |
|
7 |
|a Duloxetine Hydrochloride
|2 NLM
|
| 650 |
|
7 |
|a 9044SC542W
|2 NLM
|
| 700 |
1 |
|
|a Nakamoto, Mark
|e verfasserin
|4 aut
|
| 773 |
0 |
8 |
|i Enthalten in
|t Diabetes self-management
|d 1998
|g 21(2004), 6 vom: 30. Nov., Seite 15-8, 21-3
|w (DE-627)NLM098190385
|x 0741-6253
|7 nnns
|
| 773 |
1 |
8 |
|g volume:21
|g year:2004
|g number:6
|g day:30
|g month:11
|g pages:15-8, 21-3
|
| 912 |
|
|
|a GBV_USEFLAG_A
|
| 912 |
|
|
|a SYSFLAG_A
|
| 912 |
|
|
|a GBV_NLM
|
| 912 |
|
|
|a GBV_ILN_350
|
| 951 |
|
|
|a AR
|
| 952 |
|
|
|d 21
|j 2004
|e 6
|b 30
|c 11
|h 15-8, 21-3
|